Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based studyGemma Gatta|The Lancet Oncology|2017Cited by 498
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based studyGemma Gatta, Alice Nennecke, N. Zielonke et al.|European Journal of Cancer|2015Cited by 485
Ovarian cancerNicoletta Colombo, Ignace Vergote, Toon Van Gorp et al.|Critical Reviews in Oncology/Hematology|2006Cited by 218
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based studyLaura Botta, Stefano Rosso, Gemma Gatta et al.|The Lancet Oncology|2022Cited by 184